← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 1999Last known activity
Aug 31, 2021
Timeline
1990s
- Jun 1, 1999
Applied Genetic Technologies Corp— Founded
Drugs by trial phase (8 distinct, 9 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT04850118Study directorPhase 2/Phase 3Aug 31, 2021
- NCT04850118Lead sponsorPhase 2/Phase 3Aug 31, 2021
- NCT03316560Lead sponsorPhase 1/Phase 2Jan 31, 2018
- NCT03316560Study directorPhase 1/Phase 2Jan 31, 2018
- NCT02935517Lead sponsorPhase 1/Phase 2May 1, 2017
- NCT02935517Study directorPhase 1/Phase 2May 1, 2017
- NCT02599922Study directorPhase 1/Phase 2Feb 1, 2016
- NCT02599922Lead sponsorPhase 1/Phase 2Feb 1, 2016
- NCT02416622Study directorPhase 1/Phase 2May 1, 2015
- NCT02416622Lead sponsorPhase 1/Phase 2May 1, 2015
- NCT01054339Lead sponsorPhase 2Mar 1, 2010
- NCT00749957Lead sponsorPhase 1/Phase 2Dec 1, 2008
- NCT00430768CollaboratorPhase 1Feb 1, 2006
- NCT00002811Lead sponsorPhase 3Jul 1, 1996
- NCT00002811Study chairPhase 3Jul 1, 1996
Details
- Founded
- Alachua, Florida, US Jun 1, 1999
- Last known activity
- Aug 31, 2021